Weave Bio, the leader in AI-native regulatory automation for drug development, and strategic partner Parexel, a leading global clinical development partner, today announced that the Weave platform now ...
This article first appeared on GuruFocus. Weave Communications Inc (NYSE:WEAV) is set to release its Q1 2026 earnings on Apr 30, 2026. The consensus estimate for Q1 2026 revenue is $64.57 million, and ...
Weave Communications' introduction of the New Weave platform and early success of Weave Enterprise demonstrate strategic maturity and long-term growth potential. Q3 results show strong revenue ...
Weave's acquisition of TrueLark, a virtual receptionist, aims to enhance automation and boost profitability for SMB healthcare providers. Weave paid $35 million for TrueLark, expecting it to ...
LEHI, Utah--(BUSINESS WIRE)--Weave (NYSE: WEAV), a leading all-in-one customer experience and payments software platform for small and medium-sized healthcare businesses, has launched a fully ...
Weave Communications Inc. announced late Wednesday that its initial public offering priced at $24 a share, below the company's expected range of $25 to $28 a share. The company intends to offer 5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results